Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial | British Journal of Cancer
fee survival at three and five years for stage III colon cancer... | Download Scientific Diagram
![Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1aa850d41f53d06c3224b598001e97a93455b779/2-Table1-1.png "Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar")
Table 1 from [Chemotherapy for colorectal cancer]. | Semantic Scholar
Duration of adjuvant therapy for stage III colon cancer: No longer one size fits all | The Bulletin
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
A Report from ASCO 2007 Adjuvant Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical Research. - ppt download
Frontiers | Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
PDF) Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial | Miguel Navarro - Academia.edu
Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis - Boyne - 2020 - Cancer Medicine - Wiley Online Library
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER
Overall survival in stage II vs stage III patients (4-year follow-up in... | Download Scientific Diagram
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study | Journal of
![PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/037ec0de81994c4e5edf94d736d025133d72badf/2-Figure1-1.png "PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar")
PDF] Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. | Semantic Scholar
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and...
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer | NEJM
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Kaplan-Meier estimates of overall survival (OS) in the intent-to-treat... | Download Scientific Diagram
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial | British Journal of Cancer
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial | British Journal of Cancer
A Report from ASCO-GI 2008 and ASCO 2007 Up-to-Date Review of the Treatment of Adjuvant Colorectal Cancer Axel Grothey, MD Professor of Oncology Mayo Clinic. - ppt download
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database -
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
